Pulsed electric field ablation as a candidate to enhance the anti-tumor immune response to immune checkpoint inhibitors
- 26 November 2024
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 609, 217361
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (1R01CA247763-01A1)
- University of Missouri
- National Institutes of Health
- US Department of Veterans Affairs (CX002498-01A2)
This publication has 109 references indexed in Scilit:
- Targeting immunogenic cell death in cancerMolecular Oncology, 2020
- Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy DrugsJAMA Network Open, 2019
- Molecular and histological study on the effects of non-thermal irreversible electroporation on the liverBiochemical and Biophysical Research Communications, 2018
- p62-Mediated mitochondrial clustering attenuates apoptosis induced by mitochondrial depolarizationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2017
- Induction of apoptosis of liver cancer cells by nanosecond pulsed electric fields (nsPEFs)Medical Oncology, 2017
- Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect studyEuropean Radiology, 2014
- Changes of apoptosis in tumor tissues with time after irreversible electroporationBiochemical and Biophysical Research Communications, 2013
- Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cellsHepatology, 2010
- Pulmonary hemorrhage complicating radiofrequency ablation, from mild hemoptysis to life-threatening patternEuropean Radiology, 2010
- Tissue Ablation with Irreversible ElectroporationAnnals of Biomedical Engineering, 2005